Biotech

Arbor Biotechnologies

Arbor Biotechnologies raises $215M Series C at $800M valuation

$215M
Total Raised
Series C
Latest Round
2016
Founded
100+
Employees
830 Winter Street, Waltham, MA 02451
1 min read

Quick Facts

Valuation
$800M
Latest Round Size
$215M
Latest Round Date
November 2024

Arbor Biotechnologies: Series C Funding Round

Arbor Biotechnologies has successfully raised $215M in Series C funding, reaching a valuation of $800M.

Company Overview

Gene editing technologies

Funding Details

The Series C round was led by Lightspeed Venture Partners, with participation from Redmile Group, Agent Capital, Amplitude Ventures.

Company Information

  • Headquarters: 830 Winter Street, Waltham, MA 02451
  • Founded: 2016
  • Employees: 100+
  • Category: Biotech

Investment

Arbor Biotechnologies plans to use the funds to accelerate product development, expand its team, and scale operations globally.

About the Investors

  • Lightspeed Venture Partners: Verified investor in Series C
  • Redmile Group: Verified investor in Series C
  • Agent Capital: Verified investor in Series C
  • Amplitude Ventures: Verified investor in Series C

Key Investors

Lightspeed Venture Partners
Lead Investor
Verified investor in Series C
Redmile Group
Investor
Verified investor in Series C
Agent Capital
Investor
Verified investor in Series C
Amplitude Ventures
Investor
Verified investor in Series C

About the Author

Editorial Team
Editorial Team
Curated funding news from verified sources